Key result
Serum 25-HCC levels in ischemic heart disease patients do not differ from normal persons.
Why the study?
Are serum vitamin D (25-HCC) levels elevated in patients with ischaemic heart disease compared to normal persons?
Population
128 patients consecutively admitted for chest pain, an initial cohort of 12 patients with acute myocardial…
Design
Cross-sectional
Follow-up
4 days (for the initial 12-patient cohort)
Authors
Loading...
No difference in 25-HCC levels does not support vitamin D as IHD risk factor; challenges prior hypotheses yet leaves open prospective validation.
Cross-Sectional (n=549)
Are serum vitamin D (25-HCC) levels elevated in patients with ischaemic heart disease compared to normal persons?
Patients with ischaemic heart disease do not have elevated levels of vitamin D compared to normal individuals, challenging the hypothesis that it is a risk factor.
Lund et al. (1978) conducted a cross-sectional in Ischaemic heart disease (n=549). Serum 25-hydroxy-cholecalciferol (25-HCC) vs. Normal persons was evaluated on Serum 25-hydroxy-cholecalciferol (25-HCC) levels. Serum 25-hydroxy-cholecalciferol levels in patients with ischaemic heart disease did not differ from those measured in normal persons.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: